• Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels 

      Parikh, H; Wang, ZM; Pettigrew, KA; Jia, JP; Daugherty, S; Yeager, M; Jacobs, KB; Hutchinson, A; Burdett, L; Cullen, M; Qi, LQ; Boland, J; Collins, I; Albert, TJ; Vatten, Lars Johan; Hveem, Kristian; Njølstad, Inger; Cancel-Tassin, G; Cussenot, O; Valeri, A; Virtamo, J; Thun, MJ; Feigelson, HS; Diver, WR; Chatterjee, N; Thomas, G; Albanes, D; Chanock, SJ; Hunter, DJ; Hoover, R; Hayes, RB; Berndt, SI; Sampson, J; Amundadottir, L (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
      Measurements of serum prostate-specific antigen (PSA) protein levels form the basis for a widely used test to screen men for prostate cancer. Germline variants in the gene that encodes the PSA protein (KLK3) have been shown to be associated with both serum PSA levels and prostate cancer. Based on a resequencing analysis of a 56 kb region on chromosome 19q13.33, centered on the KLK3 gene, we fine ...
    • A genome-wide "pleiotropy scan" does not identify new susceptibility Loci for estrogen receptor negative breast cancer 

      Campa, D; Barrdahl, M; Tsilidis, KK; Severi, G; Diver, WR; Siddiq, A; Chanock, S; Hoover, RN; Ziegler, RG; Berg, CD; Buys, SS; Haiman, CA; Henderson, BE; Schumacher, FR; Le Marchand, L; Flesch-Janys, D; Lindstrom, S; Hunter, DJ; Hankinson, SE; Willett, WC; Kraft, P; Cox, DG; Khaw, KT; Tjønneland, A; Dossus, L; Trichopoulos, D; Panico, S; Van Gils, CH; Weiderpass, Elisabete; Barricarte, A; Sund, M; Gaudet, MM; Giles, G; Southey, M; Baglietto, L; Chang-Claude, J; Kaaks, R; Canzian, F (Journal article; Tidsskriftartikkel; Peer reviewed, 2014)